|
| |
| | | 53362 | | 23.01.1996 | | Pfizer AG | | 02.11.2005 | | | | | | | | | | | 01.08. | | | | 01.08. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Cabaser 1 mg | Tabletten | Tabletten (Cabergolinum 1 mg) | N04BC06 | PI | | 02 | Cabaser 2 mg | Tabletten | Tabletten (Cabergolinum 2 mg) | N04BC06 | PI | | 03 | Cabaser 4 mg | Tabletten | Tabletten () | N04BC06 | PI |
|
|
|
